---
document_datetime: 2025-06-16 15:50:38
document_pages: 2
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/foclivia-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
document_name: foclivia-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
version: success
processing_time: 1.2914362
conversion_datetime: 2025-12-27 13:13:40.869334
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Foclivia

Procedural steps taken and scientific information after the authorisation*

*Due to the Agency`s update of its procedure management systems, an additional document, reflecting the historical lifecycle may be available in the 'Assessment history' section. For the complete product lifecycle procedures, you may need to also refer to EPAR - Procedural steps taken and scientific information after authorisation (archive) .

| Application number   | Scope                                         | Opinion/ Notification 1 issued on   | Commission Decision Issued 2 / amended on   | Product Information affected 3   | Summary                                            |
|----------------------|-----------------------------------------------|-------------------------------------|---------------------------------------------|----------------------------------|----------------------------------------------------|
| Variation type IB /  | C.I.7 Deletion of: - C.I.7.a a pharmaceutical | 16/06/2025                          |                                             | SmPC,                            | To delete the pharmaceutical form Single Dose Vial |

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

| EMA/VR/0000274004                     | form - Accepted                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |            |     | Labelling and PL   | from the Foclivia marketing authorization (EU/1/09/577/003).   |
|---------------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|--------------------|----------------------------------------------------------------|
| Variation type IB / EMA/VR/0000248835 | This was an application for a group of variations following a worksharing procedure according to Article 20 of Commission Regulation (EC) No 1234/2008. B.I.b.2 Change in test procedure for active substance or starting material/reagent/intermediate used in the manufacturing process of the active substance - B.I.b.2.a Minor changes to an approved test procedure - Accepted B.I.a.2 Changes in the manufacturing process of the active substance - B.I.a.2.a Minor change in the manufacturing process of the active substance - Accepted | 25/04/2025 | N/A |                    |                                                                |